Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Burgel, Pierre Régis ^a,b,c   Paillasseur, Jean Louis ^c,d   Roche, Nicolas ^a,b,c  

^a université Paris Cité   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Initiatives BPCO Study Group   (France)

^d EFFI STAT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; COMORBIDITY; DISEASE CLASSIFICATION; EMPHYSEMA; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; PHENOTYPE; PROGNOSIS; REVIEW; CLASSIFICATION; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

CLUSTER ANALYSIS; COMORBIDITY; HUMANS; PHENOTYPE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84896273713     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/420134     Document Type: Review

References (54)

1. Halbert R. J., Natoli J. L., Gano A., Badamgarav E., Buist A. S., Mannino D. M., Global burden of COPD: systematic review and meta-analysis. European Respiratory Journal 2006 28 3 523 532 2-s2.0-33748677876 10.1183/09031936.06. 00124605 (Pubitemid 44794666)
2. Agusti A., Calverley P. M. A., Celli B., Coxson H. O., Edwards L. D., Lomas D. A., MacNee W., Miller B. E., Rennard S., Silverman E. K., Tal-Singer R., Wouters E., Yates J. C., Vestbo J., Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory Research 2010 11, article 122 2-s2.0-79551603829 10.1186/1465-9921-11-122
3. Han M. K., Agusti A., Calverley P. M., Celli B. R., Criner G., Curtis J. L., Fabbri L. M., Goldin J. G., Jones P. W., MacNee W., Make B. J., Rabe K. F., Rennard S. I., Sciurba F. C., Silverman E. K., Vestbo J., Washko G. R., Wouters E. F. M., Martinez F. J., Chronic obstructive pulmonary disease phenotypes: the future of COPD. American Journal of Respiratory and Critical Care Medicine 2010 182 5 598 604 2-s2.0-77957705828 10.1164/rccm.200912-1843CC
4. Charlson M., Charlson R. E., Briggs W., Hollenberg J., Can disease management target patients most likely to generate high costs? The impact of comorbidity. Journal of General Internal Medicine 2007 22 4 464 469 2-s2.0-34250028566 10.1007/s11606-007-0130-7 (Pubitemid 46941213)
5. Barnes P. J., Celli B. R., Systemic manifestations and comorbidities of COPD. European Respiratory Journal 2009 33 5 1165 1185 2-s2.0-66749141807 10.1183/09031936.00128008
6. Fabbri L. M., Luppi F., Beghé B., Rabe K. F., Complex chronic comorbidities of COPD. European Respiratory Journal 2008 31 1 204 212 2-s2.0-42649088839 10.1183/09031936.00114307
7. Fabbri L. M., Rabe K. F., From COPD to chronic systemic inflammatory syndrome? The Lancet 2007 370 9589 797 799 2-s2.0-34548277025 10.1016/S0140-6736(07)61383-X (Pubitemid 47320803)
8. Watz H., Waschki B., Meyer T., Magnussen H., Physical activity in patients with COPD. European Respiratory Journal 2009 33 2 262 272 2-s2.0-59649127166 10.1183/09031936.00024608
9. Sin D. D., Anthonisen N. R., Soriano J. B., Agusti A. G., Mortality in COPD: role of comorbidities. European Respiratory Journal 2006 28 6 1245 1257 2-s2.0-33845361633 10.1183/09031936.00133805 (Pubitemid 44883863)
10. Mannino D. M., Thorn D., Swensen A., Holguin F., Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. European Respiratory Journal 2008 32 4 962 969 2-s2.0-56249083570 10.1183/09031936. 00012408
11. Divo M., Cote C., de Torres J. P., Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2012 186 2 155 161 10.1164/rccm.201201- 0034OC
12. Burrows B., Fletcher C. M., Heard B. E., Jones N. L., Wootliff J. S., The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. The Lancet 1966 1 7442 830 835 2-s2.0-0014019380
13. Karon E. H., Koeslche G. A., Fowler W. S., Chronic obstructive pulmonary disease in young adults. Proceedings of the Staff Meetings of the Mayo Clinic 1960 35 307 316
14. Warren C. P. W., The nature and causes of chronic obstructive pulmonary disease: a historical perspective. The Christie Lecture 2007, Chicago, USA. Canadian Respiratory Journal 2009 16 1 13 20 2-s2.0-65449129594
15. Burrows B., The bronchial and emphysematous types of chronic obstructive lung disease in London and Chicago. Aspen Emphysema Conference 1968 9 327 338 2-s2.0-0014384705
16. Petty T. L., The history of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2006 1 1 3 14 2-s2.0-36148937646
17. Freimer N., Sabatti C., The human phenome project. Nature Genetics 2003 34 1 15 21 2-s2.0-0038670579 10.1038/ng0503-15 (Pubitemid 36548781)
18. Agustí A., Celli B., Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation. European Respiratory Journal 2011 38 4 749 751 2-s2.0-80053534329 10.1183/09031936.00062211
19. Marin J. M., Alfageme I., Almagro P., Casanova C., Esteban C., Soler-Cataluña J. J., de Torres J. P., Martínez-Camblor P., Miravitlles M., Celli B. R., Soriano J. B., Multicomponent indices to predict survival in COPD: the COCOMICS study. European Respiratory Journal 2013 42 2 323 332 10.1183/09031936.00121012
20. Celli B. R., Cote C. G., Marin J. M., Casanova C., Montes De Oca M., Mendez R. A., Plata V. P., Cabral H. J., The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England Journal of Medicine 2004 350 10 1005 1012 2-s2.0-1442306237 10.1056/NEJMoa021322 (Pubitemid 38269277)
21. Rabe K. F., Hurd S., Anzueto A., Barnes P. J., Buist S. A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., van Weel C., Zielinski J., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2007 176 6 532 555 2-s2.0-34548660457 10.1164/rccm.200703-456SO (Pubitemid 47403272)
22. Vestbo J., Hurd S. S., Agusti A. G., Jones P. W., Vogelmeier C., Anzueto A., Barnes P. J., Fabbri L. M., Martinez F. J., Nishimura M., Stockley R. A., Sin D. D., Rodriguez-Roisin R., Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2013 187 4 347 365 10.1164/rccm.201204- 0596PP
23. Agusti A., Hurd S., Jones P., Fabbri L., Martinez F., Vogelmeier C., Vestbo J., Rodriguez-Roisin R., Frequently Asked Questions (FAQs) about the GOLD, 2011 assessment proposal of COPD. European Respiratory Journal 2013 42 5 1391 1401 10.1183/09031936.00036513
24. Chanez P., Vignola A. M., O'Shaugnessy T., Enander I., Li D., Jeffery P. K., Bousquet J., Corticosteroid reversibility in COPD is related to features of asthma. American Journal of Respiratory and Critical Care Medicine 1997 155 5 1529 1534 2-s2.0-0030976501 (Pubitemid 27216654)
25. Vestbo J., Prescott E., Lange P., Jensen G., Schnohr P., Appleyard M., Nyboe J., Grønbæk M., Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. American Journal of Respiratory and Critical Care Medicine 1996 153 5 1530 1535 2-s2.0-0029947193 (Pubitemid 26141336)
26. Burgel P. R., Nesme-Meyer P., Chanez P., Caillaud D., Carré P., Perez T., Roche N., Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009 135 4 975 982 2-s2.0-64749104557 10.1378/chest.08-2062
27. Soler-Cataluña J. J., Martínez-García M. Á., Román Sánchez P., Salcedo E., Navarro M., Ochando R., Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005 60 11 925 931 2-s2.0-27744556967 10.1136/thx.2005.040527 (Pubitemid 41598207)
28. National Emphysema Treatment Trial Research Group, Patients at high risk of death after lung-volume-reduction surgery. The New England Journal of Medicine 2001 345 1075 1083 10.1056/NEJMoa11798
29. Hurst J. R., Vestbo J., Anzueto A., Locantore N., Müllerova H., Tal-Singer R., Miller B., Lomas D. A., Agusti A., MacNee W., Calverley P., Rennard S., Wouters E. F. M., Wedzicha J. A., Susceptibility to exacerbation in chronic obstructive pulmonary disease. The New England Journal of Medicine 2010 363 12 1128 1138 2-s2.0-77956689733 10.1056/NEJMoa0909883
30. Wardlaw A. J., Silverman M., Siva R., Pavord I. D., Green R., Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clinical and Experimental Allergy 2005 35 10 1254 1262 2-s2.0-33644843042 10.1111/j.1365-2222.2005.02344.x
31. Haldar P., Pavord I. D., Shaw D. E., Berry M. A., Thomas M., Brightling C. E., Wardlaw A. J., Green R. H., Cluster analysis and clinical asthma phenotypes. American Journal of Respiratory and Critical Care Medicine 2008 178 3 218 224 2-s2.0-48249085691 10.1164/rccm.200711-1754OC
32. Moore W. C., Meyers D. A., Wenzel S. E., Teague W. G., Li H., Li X., D'Agostino R. Jr., Castro M., Curran-Everett D., Fitzpatrick A. M., Gaston B., Jarjour N. N., Sorkness R., Calhoun W. J., Chung K. F., Comhair S. A. A., Dweik R. A., Israel E., Peters S. P., Busse W. W., Erzurum S. C., Bleecker E. R., Identification of asthma phenotypes using cluster analysis in the severe asthma research program. American Journal of Respiratory and Critical Care Medicine 2010 181 4 315 323 2-s2.0-76149146032 10.1164/rccm.200906-0896OC
33. Altenburg W. A., de Greef M. H. G., Ten Hacken N. H. T., Wempe J. B., A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients. Respiratory Medicine 2012 106 5 694 700 2-s2.0-84859100609 10.1016/j.rmed.2011.11.008
34. Burgel P.-R., Paillasseur J.-L., Caillaud D., Tillie-Leblond I., Chanez P., Escamilla R., Court-Fortune I., Perez T., Carré P., Roche N., Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. European Respiratory Journal 2010 36 3 531 539 2-s2.0-77953389042 10.1183/09031936.00175109
35. Burgel P. R., Roche N., Paillasseur J. L., Tillie-Leblond I., Chanez P., Escamilla R., Court-Fortune I., Perez T., Carre P., Caillaud D., Clinical COPD phenotypes identified by cluster analysis: validation with mortality. European Respiratory Journal 2012 40 2 495 496 10.1183/09031936.00228511
36. Fens N., van Rossum A. G., Zanen P., van Ginneken B., van Klaveren R. J., Zwinderman A. H., Sterk P. J., Subphenotypes of mild-to-moderate COPD by factor and cluster analysis of pulmonary function, CT imaging and breathomics in a population-based survey. COPD 2013 10 3 277 285 10.3109/15412555.2012.744388
37. Garcia-Aymerich J., Gómez F. P., Benet M., Farrero E., Basagaña X., Gayete À., Paré C., Freixa X., Ferrer J., Ferrer A., Roca J., Gáldiz J. B., Sauleda J., Monsó E., Gea J., Barberà J. A., Agustí À., Antó J. M., Identification and prospective validation of clinically relevant Chronic Obstructive Pulmonary Disease (COPD) subtypes. Thorax 2011 66 5 430 437 2-s2.0-79954994400 10.1136/thx.2010.154484
38. Paoletti M., Camiciottoli G., Meoni E., Bigazzi F., Cestelli L., Pistolesi M., Marchesi C., Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes. Journal of Biomedical Informatics 2009 42 6 1013 1021 2-s2.0-70350575210 10.1016/j.jbi.2009.05.008
39. Pistolesi M., Camiciottoli G., Paoletti M., Marmai C., Lavorini F., Meoni E., Marchesi C., Giuntini C., Identification of a predominant COPD phenotype in clinical practice. Respiratory Medicine 2008 102 3 367 376 2-s2.0-38749103496 10.1016/j.rmed.2007.10.019
40. Vanfleteren L. E., Spruit M. A., Groenen M., Gaffron S., van Empel V. P., Bruijnzeel P. L., Rutten E. P., Op 't Roodt J., Wouters E. F., Franssen F. M., Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2013 187 7 728 735 10.1164/rccm.201209-1665OC
41. Vogt W., Nagel D., Cluster analysis in diagnosis. Clinical Chemistry 1992 38 2 182 198 2-s2.0-0026608405
42. Tamayo P., Slonim D., Mesirov J., Zhu Q., Kitareewan S., Dmitrovsky E., Lander E. S., Golub T. R., Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 2907 2912 2-s2.0-0033027794 10.1073/pnas.96.6.2907 (Pubitemid 29148817)
43. Burgel P. R., Paillasseur J. L., Peene B., Dusser D., Roche N., Coolen J., Troosters T., Decramer M., Janssens W., Two distinct Chronic Obstructive Pulmonary Disease (COPD) phenotypes are associated with high risk of mortality. PLoS ONE 2012 7 12 e51048 10.1371/journal.pone.0051048
44. Selvaraj S., Natarajan J., Microarray data analysis and mining tools. Bioinformation 2011 6 3 95 99 10.6026/97320630006095
45. Prosperi M. C., Sahiner U. M., Belgrave D., Sackesen C., Buchan I. E., Simpson A., Yavuz T. S., Kalayci O., Custovic A., Challenges in identifying asthma subgroups using unsupervised statistical learning techniques. American Journal of Respiratory and Critical Care Medicine 2013 188 11 1303 1312 10.1164/rccm.201304-0694OC
46. Basagaña X., Barrera-Gómez J., Benet M., Antó J. M., Garcia-Aymerich J., A framework for multiple imputation in cluster analysis. American Journal of Epidemiology 2013 177 7 718 725 10.1093/aje/kws289
47. Weatherall M., Travers J., Shirtcliffe P. M., Marsh S. E., Williams M. V., Nowitz M. R., Aldington S., Beasley R., Distinct clinical phenotypes of airways disease defined by cluster analysis. European Respiratory Journal 2009 34 4 812 818 2-s2.0-69249098135 10.1183/09031936.00174408
48. Disantostefano R. L., Li H., Rubin D. B., Stempel D. A., Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis. BMJ Open 2013 3 e001838:10.1136/bmjopen-2012-001838
49. Bafadhel M., McKenna S., Terry S., Mistry V., Reid C., Haldar P., McCormick M., Haldar K., Kebadze T., Duvoix A., Lindblad K., Patel H., Rugman P., Dodson P., Jenkins M., Saunders M., Newbold P., Green R. H., Venge P., Lomas D. A., Barer M. R., Johnston S. L., Pavord I. D., Brightling C. E., Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. American Journal of Respiratory and Critical Care Medicine 2011 184 6 662 671 2-s2.0-80052936263 10.1164/rccm.201104-0597OC
50. Rutten F. H., Cramer M. M., Grobbee D. E., Sachs A. P. E., Kirkels J. H., Lammers J. J., Hoes A. W., Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. European Heart Journal 2005 26 18 1887 1894 2-s2.0-24344473823 10.1093/eurheartj/ehi291 (Pubitemid 41253302)
51. Gartside P. S., Wang P., Glueck C. J., Prospective assessment of coronary heart disease risk factors: the NHANES I epidemiologic follow-up study (NHEFS) 16-year follow-up. Journal of the American College of Nutrition 1998 17 3 263 269 2-s2.0-0031802161 (Pubitemid 28265501)
52. Hersh C. P., DeMeo D. L., Al-Ansari E., Carey V. J., Reilly J. J., Ginns L. C., Silverman E. K., Predictors of survival in severe, early onset COPD. Chest 2004 126 5 1443 1451 2-s2.0-8744222654 10.1378/chest.126.5.1443 (Pubitemid 39525015)
53. Carolan B. J., Sutherland E. R., Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances. The Journal of Allergy and Clinical Immunology 2013 131 3 627 634 10.1016/j.jaci.2013.01.010
54. US Food and Drug Administration, Webinar Draft GFI on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products. 2013, http://www.fda.gov/drugs/ucm343578.htm